We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Risk of Contamination Reduced During Blood Culture Collection

By Labmedica staff writers
Posted on 28 Jul 2008
A newly developed kit provides a safer and easier process for blood culture collection that can help minimize contamination.

Blood cultures are critical in the early detection stage for sepsis--a severe, whole-body immune response to infection. More...
Sepsis is a serious condition, which is caused by microbes or their toxins in blood or tissues. The new kit minimizes the risk of false-positive results from the lab, which can be expensive for both patients and hospitals.

The new WorkSafe blood culture kit includes BacT/Alert three-dimensional (3D) blood culture bottles, made of a multi-layer polycarbonate instead of glass, which decreases the risk of breakage and blood or body fluid exposures. This improves worker and patient safety by limiting the amount of potential exposure to biohazardous materials. The lightweight plastic bottles can be sent through pneumatic transportation tube systems without custom holders.

Launched by bioMérieux (Marcy l'Etoile, France), the kit is a key element of the company's WorkSafe campaign that equips hospital workers with one simple kit with all necessary components for safe and efficient blood culture-collection. The kit eliminates the need for nurses or phlebotomists to manually pull loose and disparate pieces together for blood culture collection. The kit also contains a disposal bag for all biohazardous materials.

bioMérieux provides diagnostic solutions (reagents, instruments, software), which determine the source of disease and contamination to improve patient health and ensure consumer safety. The products are used for diagnosing infectious diseases and providing high medical value results for cardiovascular emergencies, and cancer screening and monitoring. They are also used for detecting microorganisms in agri-food, pharmaceutic, and cosmetic products.


Related Links:
bioMérieux

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Manual Pipetting Aid
Pipette Controllers macro
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.